Connect with us

Health

NCDC DG, Ihekweazu, To Resume WHO Job In November

NCDC DG, Ihekweazu, to resume WHO job Nov

NCDC DG, Ihekweazu, To Resume WHO Job In November

The Director General of the Nigeria Centre for Disease Control (Chikwe Ihekweazu, has gotten an appointment with the World Health Organisation (WHO) as its Assistant Director General of Health Emergency Intelligence and is set to resume on November 1, 2021.

This was contained in a letter signed by the WHO Director General, Tedros Ghebreyesus, on Tuesday, addressed to staff members of the organisation.

An excerpt reads, “I am pleased to welcome Dr Chikwe Ihekweazu as an Assistant Director-General for Health Emergency Intelligence from November 1, 2021.

“He will lead the work on strengthening pandemic and epidemic intelligence globally, including heading the WHO Hub for Pandemic and Epidemic Intelligence in Berlin.

“Dr Ihekweazu is currently the Director-General of Nigeria Centre for Disease Control. He was trained as an infectious disease epidemiologist, has over 20 years of experience working in senior public health and leadership positions in several National Public Health Institutes, including the South African National Institute for Communicable Diseases, the United Kingdom’s Health Protection Agency, and Germany’s Robert Koch Institute.

“He has led several short-term engagements for WHO, mainly in response to major infectious disease outbreaks around the world.

“Dr Ihekweazu, a Nigerian national, who was born in Germany, is a graduate of the College of Medicine, University of Nigeria and has a Masters in Public Health from the Heinrich-Heine University, Dusseldorf, Germany.

“In 2003, he was awarded a Fellowship for the European Programme for Intervention Epidemiology Training and subsequently completed his Public Health specialization in the United Kingdom. He is widely published in medical peer-review journals.”

 

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

WHO sets targets to end Mpox outbreaks in Africa

The World Health Organisation, WHO, has set a target of halting mpox outbreaks in Africa within the next six months.

This announcement came as the first vaccine shipments are expected to arrive in the Democratic Republic of Congo, DRC, in the coming days.

Africa, particularly the DRC, with over 18,000 suspected cases and 629 deaths, has received only a fraction of the vaccines to combat the virus.

At a press briefing on Monday, September 2, WHO Director-General, Dr Tedros Adhanom Ghebreyesus expressed confidence in ending the outbreaks, citing strong government leadership and collaborative partnerships.

In August, WHO declared mpox outbreaks a global emergency to spur a more robust international response even though a new strain of mpox known as clade1b, has been identified in many countries, including Burundi, Cameroon, Rwanda, and Kenya.

The potentially more contagious variant of the virus was detected in Congo in May, prompting heightened concerns among health officials.

WHO estimates that approximately 230,000 vaccines could soon be sent to Congo and other affected countries. The WHO is also implementing educational campaigns to inform people in outbreak areas about preventing the spread of the disease.

Africa’s Centers for Disease Control and Prevention has said it aims to receive 380,000 vaccine doses from donors, including the US and the EU, which falls short of the quantity required to eradicate the outbreaks.

Continue Reading

Health

No recorded case of mpox in Ogun- Govt

The Ogun State Commissioner for Health, Dr Tomo Coker, on Wednesday said the state has not recorded any case of Mpox across the 20 local government areas of the state.

She disclosed this in a statement made available to journalists in Abeokuta, saying that the state has maintained a high level of surveillance since the global outbreak in 2022.

“Mpox is a disease of public health importance and the World Health Organization (WHO) has declared outbreaks of a more virulent strain in some countries. Some states in Nigeria have also reported outbreaks of Mpox,” she said.

“Ogun State Ministry of Health is aware of this public health threat and has instituted appropriate measures to prevent it, detect it early, and respond as appropriate.

“The last case of Mpox in Ogun State was in May 2023 and no confirmed case has been reported in Ogun State to date.

“As of 18th August 2024, the state surveillance system has reported 151 suspected cases of Mpox across the state but none of the suspected cases has been confirmed to be Mpox though 53 returned positive for Chicken Pox.

“We are aware of the Chicken Pox cases in the state and the necessary measures are already in place.

“Sensitization of the public on Mpox, Chickenpox, and other priority diseases is ongoing through established platforms. Therefore, there is no need to panic.”

Continue Reading

Health

US donates 10,000 monkeypox vaccine doses to Nigeria

The United States government donated 10,000 doses of the Jynneos vaccine to Nigeria to aid in the fight against monkeypox on Tuesday.

The Jynneos vaccine, approved by the U.S. Food and Drug Administration, is designed to prevent smallpox and monkeypox in adults aged 18 and older who are at risk of infection.

During the official handover ceremony in Abuja, Prof. Muhammad Pate, the Coordinating Minister of Health and Social Welfare, expressed gratitude to the U.S. government for the generous donation.

Represented by Permanent Secretary Daju Kachollom, Pate emphasised the Federal Government’s commitment to improving public health in Nigeria.

He said, “This is a spirit of cooperation and collaboration through the years, and this vaccine will be of great help to us.

“The Federal Ministry of Health understands the importance of having a healthy nation, so all the policies that we implement and the collaborations are focused on ensuring our citizens’ health.”

Pate also extended thanks to other development partners, including USAID, PEPFAR, WHO, UNICEF, and various UN organisations, for their continued support.

He highlighted the importance of addressing public health concerns, particularly diseases like monkeypox that pose significant risks to the population.

Monkeypox, a rare viral zoonotic disease, primarily affects remote villages in Central and West Africa near tropical rainforests.

It is caused by the monkeypox virus, which belongs to the orthopoxvirus genus, including smallpox and cowpox.

Following the eradication of smallpox, monkeypox has become a prominent concern within the orthopoxvirus family.

On August 13, 2024, the Africa Centres for Disease Control and Prevention declared monkeypox a public health emergency of continental security.

As of last Friday, Nigeria’s Centre for Disease Control and Prevention reported 40 confirmed cases of monkeypox out of 830 suspected cases nationwide.

Continue Reading
Advertisement

Trending